ClinicalTrials.gov

History of Changes for Study: NCT04405570
Safety, Tolerability and Efficacy of Molnupiravir (EIDD-2801) to Eliminate Infectious Virus Detection in Persons With COVID-19
Latest version (submitted February 14, 2022) on ClinicalTrials.gov
  • A study version is represented by a row in the table.
  • Select two study versions to compare. One each from columns A and B.
  • Choose either the "Merged" or "Side-by-Side" comparison format to specify how the two study versions are to be displayed. The Side-by-Side format only applies to the Protocol section of the study.
  • Click "Compare" to do the comparison and show the differences.
  • Select a version's Submitted Date link to see a rendering of the study for that version.
  • The yellow A/B choices in the table indicate the study versions currently compared below. A yellow table row indicates the study version currently being viewed.
  • Hover over the "Recruitment Status" to see how the study's recruitment status changed.
  • Study edits or deletions are displayed in red.
  • Study additions are displayed in green.
Study Record Versions
Version A B Submitted Date Changes
1 May 26, 2020 None (earliest Version on record)
2 June 1, 2020 Study Status, Contacts/Locations, Eligibility and Study Description
3 June 16, 2020 Recruitment Status, Study Status, Contacts/Locations and Oversight
4 July 28, 2020 Study Status, Eligibility and Study Description
5 September 10, 2020 Arms and Interventions, Study Status, Outcome Measures, Study Design and Study Description
6 September 28, 2020 Contacts/Locations and Study Status
7 September 30, 2020 Contacts/Locations and Study Status
8 October 1, 2020 Study Status
9 October 5, 2020 Study Status and Study Identification
10 October 9, 2020 Contacts/Locations and Study Status
11 October 9, 2020 Contacts/Locations and Study Status
12 October 21, 2020 Contacts/Locations and Study Status
13 November 4, 2020 Study Status and Contacts/Locations
14 November 13, 2020 Contacts/Locations and Study Status
15 November 25, 2020 Contacts/Locations and Study Status
16 December 7, 2020 Study Status, Arms and Interventions and Study Design
17 January 25, 2021 Recruitment Status, Study Status and Contacts/Locations
18 February 18, 2021 Recruitment Status, Study Status and Study Design
19 February 22, 2021 Study Status
20 January 18, 2022
Quality Control Review has not concluded Returned: January 24, 2022
Arms and Interventions, Outcome Measures, Study Status, Study Description, Document Section, References, Eligibility, Sponsor/Collaborators and Study Identification
21 February 9, 2022
Quality Control Review has not concluded Returned: February 10, 2022
Outcome Measures, Baseline Characteristics, Contacts/Locations, Arms and Interventions, Document Section, Study Status, Participant Flow, Study Description, IPDSharing, References, Eligibility, Conditions and Study Identification
22 February 14, 2022 Study Status, Outcome Measures, Document Section, Participant Flow
Comparison Format:

U.S. National Library of Medicine | U.S. National Institutes of Health | U.S. Department of Health & Human Services